My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
SU0000077_SSC RPT
Environmental Health - Public
>
EHD Program Facility Records by Street Name
>
D
>
DE VRIES
>
23755
>
2600 - Land Use Program
>
MS-00-14
>
SU0000077_SSC RPT
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
4/8/2022 5:23:23 PM
Creation date
3/29/2022 1:34:31 PM
Metadata
Fields
Template:
EHD - Public
ProgramCode
2600 - Land Use Program
FileName_PostFix
SSC RPT
RECORD_ID
SU0000077
PE
2622
FACILITY_NAME
MS-00-14
STREET_NUMBER
23755
Direction
N
STREET_NAME
DE VRIES
STREET_TYPE
RD
City
LODI
Zip
95240
ENTERED_DATE
8/8/2001 12:00:00 AM
SITE_LOCATION
23755 N DEVRIES RD
RECEIVED_DATE
6/13/2000 12:00:00 AM
P_LOCATION
99
P_DISTRICT
004
QC Status
Approved
Scanner
SJGOV\sballwahn
Tags
EHD - Public
Jump to thumbnail
< previous set
next set >
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
216
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
U.S. EPA IRIS Substance rile-Norflurazon:CASRN 27314-13-2 <br /> http://www.epa.gov/ngispgm3/iris/subst/0082.htm <br /> congestion, and swelling of the hepatocytes. Thyroid changes involved a <br /> slight increase in colloidal vacuoles. The NOEL for Norflurazon in this study <br /> was 150 ppm. <br /> I <br /> _LA.3. UNCERTAINTY AND MODIFYING FACTORS (ORAL RfD) <br /> OF -- An uncertainty factor of 100 was used to account for the inter- and <br /> intraspecies differences. An additional OF of 10 to account for the <br /> subchronic (6-month) duration of the dog study was not considered necessary <br /> since comparing the results of the 90-day rat study and the life time rat <br /> study does not indicate that Norflurazon exerts toxic effects at lower doses <br /> when exposure is of a chronic nature as compared to subchronic exposure. <br /> MF -- None <br /> _I.A.4. ADDITIONAL COMMENTS (ORAL RfD) <br /> Norflurazon has been found to be associated with an increased incidence of <br /> hepatomas in male mice at the highest dose in the chronic mouse study. The <br /> available reviews and risk assessments are included here. <br /> Data Considered for Establishing the RfD <br /> 1) 6-Month Feeding - dog: Principal study - see discussion above; core grade <br /> minimum <br /> 2) 2-Year Feeding - rat: NOEL=375 ppm (18.75 mg/kg/day) ; LEL=1025 ppm (51.25 <br /> mg/kg/day) (inhibition of body weight gain; high BUN and reduced 2, 3- <br /> diphosphoglyceric acid; increased mortality; increased liver, kidney, and <br /> ovary weights; fatty changes in adrenal; endometritis; increased chromophobe <br /> adenomas in the pituitary; medullary or cortical hypertrophy in adrenals; <br /> casts in kidneys) ; core grade minimum (Sandoz, Inc. , 1975a) <br /> 3) 90-Day Feeding - rat: NOEL=500 ppm (25 mg/kg/day) ; LEL=2500 ppm (250 <br /> mg/kg/day) (increased liver-to-body weight ratios) ; no core grade (Sandoz, <br /> Inc., 1971) <br /> 4) 3-Generation Reproduction - rat: NOEL=375 ppm (18.75 mg/kg/day) ; LEL=1025 <br /> ppm (51.25 mg/kg/day) (reduced fertility, gestation, and viability) ; core <br /> grade minimum (Sandoz, Inc. , 1975b) <br /> 5) Teratology - rat: NOEL (maternal, fetal, teratogenic)=400 mg/kg/day <br /> (highest dose tested) ; core grade minimum (Sandoz, Inc. , 1972) <br /> 6) Teratology - rabbit: Maternal NOEL=30 mg/kg/day; Maternal LEL=60 mg/kg/day <br /> (decreased weight gain, 2/15 aborted) ; Fetotoxic NOEL=10 mg/kg/day; Fetotoxic <br /> LEL=30 mg/kg/day (decreased weight; incomplete ossification) ; core grade <br /> guideline (Sandoz, Inc. , 1983) <br /> Other Data Reviewed <br /> 1) 2-Year Feeding - mice: NOEL=340 ppm (50 mg/kg/day) ; LEL=1360 ppm (200 <br /> mg/kg/day) (increased liver/body weight ratios; hyperplasia, hypertrophy) ; <br /> core grade minimum (Sandoz, Inc. , 1975c) <br /> of 7 <br /> 5/15,100 11:14 AM <br />
The URL can be used to link to this page
Your browser does not support the video tag.